Latest Conference Articles

New research suggests that patients with allergic rhinitis face significantly lower risks for heart attacks, cerebrovascular disease, and all-cause mortality.

Although there appears to be no difference in blood pressure reduction in patients who take aspirin at bedtime compared to those who take it when they awake in the morning, bedtime aspirin may be associated with reduced morning platelet reactivity.

Patients with heart failure who received left ventricle augmentation with Algisyl-LVR hydrogel implant experienced improved quality of life and functional capacity compared to similar patients treated with optimal medical therapy.

Treating Hispanic patients with stable CAD with daily low-dose aspirin plus ticagrelor provided lower levels of on-treatment platelet reactivity with a faster onset and greater extent of platelet inhibition, compared to treatment with aspirin plus clopidogrel.

Creating a safer environment for clinicians and patients starts with better formalized reporting of aggressive and violent behavior, and should also include more rigorous screening and assessment for risk markers of violent behavior.

A recent anonymous survey among nephrologists suggests that patients' social support, ability to understand the transplant process, and age are the most important factors influencing nephrologists' decisions to exclude them from kidney transplant referral.

In his presentation, George Therapondos, MD, a hepatologist at the Ochsner Medical Center, detailed how to manage inpatients with cirrhosis that progresses to liver failure and gastrointestinal bleeding.

Patients who have chronic kidney disease (CKD) and end-stage renal disease (ESRD) require 20% less warfarin and more monitoring for bleeding than patients who have normal kidney function.

Primary prevention measures for upper GI bleeding should include NSAIDs, antiplatelet therapy, and anticoagulants appropriately, while secondary preventive measures should include testing and treating H. pylori and using long-term PPIs when appropriate.

Watchful waiting in patients with chronic hepatitis C (HCV) genotype 1 infection may increase the number of advanced liver disease cases, according to a poster presented at the 2013 American Association for the Study of Liver Disease (AASLD) meeting held in Washington, DC.

Plenary session at CHEST 2013 focused on the impact of early warning scores, medical response teams, availability of critical care attending intensivists, and other quality measures in intensive care.

Case study presented at CHEST 2013 details the experience of a patient with hepatitis C who, after undergoing liver transplant, died after developing a serious lung infection and other complications.

Study results presented at CHEST 2013 show that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure.

Study results show patients with the disorder report a sever burden of illness, with high rates of hospital and emergency room visits and significant negative impact on activities of daily living.

Patients with advanced Alzheimer's disease treated with 13.3 mg rivastigmine patch showed greater improvements in cognitive, functional, and behavioral performance from baseline compared to patients who received 4.6 mg patches.

Study results show that SIRS on admission and at 72 hours after is associated with a higher incidence of pancreatic necrosis, an important risk factor contributing to death in patients with severe acute pancreatitis.

Two studies at the American College of Gastroenterology's 78th Annual Scientific Meeting analyzed the health outcomes of inflammatory bowel disease in the U.S. and Canada.

Clinicians can use the MSPT, an iPad-based neurological performance test that simulates and extends the Multiple Sclerosis Functional Composite, to measure motor and visual function in patients with multiple sclerosis.

Implementation of computerized customized order entry sets in a large urban hospital reduced HIV medication error rates by more than 35%.

Primary care physicians should be aware of the signs and symptoms of common liver conditions, and incorporate the latest laboratory tests and diagnostic procedures into practice.

Study results presented at the 2013 United States Conference on AIDS show that both combo drugs have a similar efficacy profile in ART-naïve patients, but patients treated with Complera reported fewer and less severe side effects.

Increased spending for treatment of HIV patients does not necessarily lead to a more positive clinical outcome, according to a new study presented at the 2013 United States Conference on AIDS.

Mary Lynn McPherson, PharmD, BCPS, CPE, FASPE, shows healthcare professionals how to apply an equianalgesic opioid dosing chart to 12 complicated patient cases requiring an opioid switch.

Study results show improvements in body composition, intrahepatic lipids, and cardiovascular risk markers in obese men treated with growth hormone for six months compared with placebo.

According to a recent retrospective study, orlistat is not associated with hepatotoxic effects after one year of use and it contributes to weight loss in obese patients.

Phase III studies show LDMP to be safe and effective for treatment of vasomotor symptoms in menopausal women.

Physicians must consider a range of factors when initiating treatment with disease-modifying drug therapy and be prepared to switch to another first- or second-line option if the patient fails to respond.

Treating patients with multiple sclerosis who opt to use only supplements and other complementary and alternative approaches requires a great deal of tact and education, and input and support from all members of the multidisciplinary treatment team.